Pharma Journalist -

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Opdivo(nivolumab) 360 mg (injection for intravenous use) in combination with platinum-doublet…
Read More...

The countdown has begun for the most prestigious pharmaceutical conclave that is about to kick off in Hyderabad on April 7, 2022.  The last few seats to this dynamic conference…
Read More...

Newomics Inc., a biotechnology company commercializing mass spectrometry solutions for molecular detection, announced collaborations with Bruker Corporation, a company with…
Read More...

Helsinn Group (Helsinn), a fully integrated, global biopharma company with a diversified pipeline of innovative oncology assets and strong track-record of commercial execution, and…
Read More...

BeiGene announced that BRUKINSA (zanubrutinib) has been approved by Health Canada for the treatment of adult patients with marginal zone lymphoma (MZL) who have received at least one…
Read More...

Inhibrx, Inc. announced that the U.S. Food and Drug Administration, or FDA, has granted orphan-drug designation for INBRX-101 for the treatment of alpha-1 antitrypsin deficiency, or…
Read More...

Epsilogen Ltd, a global leader in the development of novel immunoglobulin E (IgE) antibodies to treat cancer, announced it has secured £30.75 million ($41.20 million) in an…
Read More...

Quoin Pharmaceuticals Ltd. announced that its wholly-owned subsidiary, Quoin Pharmaceuticals, Inc., has extended its exclusive Distribution Agreement with ER-Kim, a partner for biotech…
Read More...

Assessing device development and regulation for advanced innovation SMi’s 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA…
Read More...

Injectable Drug devices, London, UK 11th May to 12th May 2022, London, United Kingdom www.injectable-drug-delivery.com/ Delivery Innovations in Formulation and Device Design…
Read More...